(Q33343719)

26 July 2017

title

Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study (English)

1 reference

ORCID Public Data File 2021

26 July 2017

1 reference

1 reference

author name string

H Soto Parra

1

1 reference

26 July 2017

R Cavina

2

1 reference

26 July 2017

F Latteri

3

1 reference

26 July 2017

A Sala

4

1 reference

26 July 2017

M Dambrosio

5

1 reference

26 July 2017

G Antonelli

6

1 reference

26 July 2017

E Morenghi

7

1 reference

26 July 2017

M Alloisio

8

1 reference

26 July 2017

G Ravasi

9

1 reference

26 July 2017

A Santoro

10

1 reference

26 July 2017

publication date

1 July 2002

1 reference

26 July 2017

1 reference

26 July 2017

volume

13

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

1080-1086

1 reference

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF186

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDF186

1 reference

release_tvfbh6cegvckpn6ei3ogj44h44

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tvfbh6cegvckpn6ei3ogj44h44

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference